search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
CONTINUING EDUCATION TEST


The current state of SARS-CoV-2 antibody tests and their future potential uses DECEMEBER 2021 [This form may be photocopied. It is no longer valid for CEUs after June 30, 2023] Passing scores of 70 percent or higher are eligible for 1 contact hour of P.A.C.E. credit.


TEST QUESTIONS Circles must be filled in, or test will not be graded. Shade circles like this: ONot like this:O


1. Studies have shown that N and S1 ELISAs detect SARS-CoV-2 antibodies with high specificity.


{ A True


{A. N and S {B. M and S


{B. False


2. CoV-2 elicit antibody responses to N, S, RBD and other proteins, but vaccinated individuals have antibodies to the SARS-CoV-2 ________ proteins.


{C. N and RBD {D. S and RBD


3. Studies have shown that N and S1 ELISAs detect SARS CoV-2 antibodies with high specificity, in comparison to_____________, due to the S2 subunit being highly conserved among coronaviruses compared to S1.


{A. 0RBD {B. the full-length S protein {C. the full-length N protein {D. the ectodomain


4. Which of the following statements are false?


{A. IgM tests typically have lower sensitivity to detect past infection compared to IgG


{B. Tests designed to detect and differentiate between IgM and IgG in combination and


or total antibody.


{D. Combined IgG/IgM assays are less sensitive than assays that measure either


IgA typically have lower specificity than IgG or total antibody.


{E. Total or IgG are preferred due to increased sensitivity and specificity compared to


antibody separately. IgG/IgM, IgM, or IgA


5. The S protein is located on the surface of virus protruding from the envelope, functions to facilitate virus entry into host cells, and is comprised of three segments: _______________ ________________________.


{A. the ectodomain, single-pass transmembrane, and intracellular tail


{B. N protein, S protein, and RBD {C. nucleocapsid, flagella, and mitochondria {D. None of the above


6. Which of the following statements are not true?


{A. Monoclonal antibody therapy administration is time sensitive and must


{B. For tMab therapy, a point of care SARS CoV-2 Ab test solution is not optimal.


start as soon as possible post exposure or within 7 days.


{C. Presence of SARS CoV-2 antibodies in these patients could be indicative of an


adequate immune response from previous exposure or vaccination.


{D. Individuals with detectable antibodies would not be candidates for tMab


treatment


7. Which of the following are not part of the ectodomain?


{A. S1 subunit {B. N protein


{A. the spike protein {B. the mitochondria {C. the ectodomain {D. the nucleocapsid


9. Which of the following is not a type of nAb test?


{A. Virus neutralization tests (VNT) {B. Aggressive neutralization tests (aVNT) {C. Pseudovirus neutralization tests (pVNT) {D. Competitive neutralization tests (cVNT)


10. Binding antibody tests detect the presence of antibodies to the SARS-CoV-2 virus, but the antibodies detected are ________________________ immunity.


{A.defenders of {B. always conferring {C. not necessarily capable of conferring {D. building up


11. Binding antibody tests employ several different types of assay methodologies including:


{A. lateral flow (LF) and microfluidic immunoassay


{B. chemiluminescence (CIA) {D. all of the above


{C. enzyme linked immunosorbent assay (ELISA)


12. Serology tests ______________ for diagnosis of infection.


{A. are not suitable {B. are always used {C. are common {D. are just as good as other methods


13. Negative results _______________ in SARS-CoV-2 infected individuals due to lack of antibody production in the early stages of infection.


{A. will never happen {B. may occur {C. will always occur {D. rarely occur


{C. RBD {D. S2 subunit


8. The N protein is highly conserved among the CoV genus, is an immunodominant protein, and is found within the virus on_____________.


14. False positives can result from cross reactivity with preexisting antibodies from previous infection from other coronaviruses____________.


{A. that cause the common cold (229E, NL62, OC43, and HKU1).


{B. that cause SARS-CoV-2 or MERS-CoV. {C. with antibody tests with low specificity. {D. all answers are correct


15. ____________ responses tend to decrease fairly rapidly, with IgG responses being much more durable over time.


{A. Immune {B. Emotional


{B. Antibodies resulting from SARS CoV-2 infection are generally detectable within


symptom onset.


{C. IgA and IgM antibodies can be detected as early as 5 days after infection, with


10-14 days post symptom onset.


{D. Antibodies are detectable within 3 days of infection.


levels increasing in the second and third weeks.


17. Almost all immunocompetent individuals mount an antibody response to SARS CoV-2 infection and ________ of individuals that do mount an antibody response, have detectable, neutralizing antibodies to SARS CoV-2,


{A. 20% {B. 50%


{C. 75% {D. 90%


18. Asymptomatic individuals may seroconvert ______________.


{A. as soon as they get infected {B. upon viral impact {C. later in the course of infection or not at all {D. about seven-14 days after infection


19. Asymptomatic individuals have _________ IgG levels compared to symptomatic patients.


{A. higher {B. lower {C. the same {D. earlier detectable


20. Asymptomatic patients may mount a ________ response and titers may diminish _______.


{A. weaker, earlier {B. stronger, earlier {C. weaker, later {D. stronger, later


Tests can be taken online or by mail. Easy registration and payment options are available through NIU by following the links found at www.mlo-online.com/ce. PLEASE PRINT CLEARLY


NAME CITY PHONE P = Poor; E = Excellent


1. To what extent did the article focus on or clarify the objectives?


P E


2. To what extent was the article well-organized and readable?


P E


3. How will you use the CE units? state license


recertification


employment other


STATE ZIP MAILING ADDRESS INSTITUTION/FACILITY E-MAIL ADDRESS


Send your $20 check payable to Northern Illinois University with this form to: University Outreach Services, Northern Illinois University, DeKalb, IL 60115-2860 Phone: 815-753-0031 FEE NOT REFUNDABLE OR TRANSFERABLE


CE Licensure Information for FL and CA:


FL: Your FL license number:____________________ (required for CE credit)


CA: Accrediting Agency: 0001 (for use in submitting your CE credits to CA)


MLO and Northern Illinois University (NIU), DeKalb, IL, are co-sponsors in offering continuing education units (CEUs) for this issue’s CE article. CEUs or contact hours are granted by the College of Health and Human Sciences at Northern Illinois University, which has been approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.®


program. Approval as a provider of continuing education programs has been granted by the


state of Florida (Provider No. JP0000496). Continuing education credits awarded for successful completion of this test are acceptable for the ASCP Board of Registry Continuing Competence Recognition Program. Readers who pass the test successfully (scoring 70% or higher) will receive a certificate for 1 contact hour of P.A.C.E.® credit. Participants should allow three to five weeks for receipt of certificate. The fee for this continuing education test is $20. This test was prepared by Amanda Voelker, MPH, MT(ASCP), MLS, Clinical Education Coordinator, School of Health Studies, Northern Illinois University, DeKalb, IL


16 DECEMBER 2021 MLO-ONLINE.COM HOME WORK


{C. IgM and IgA {D. Ketone


16. Which of the following is not true?


{A. IgG antibodies were shown to be detectable around 7-14 days after


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54